Description
Retatrutide is an investigational medication being studied for the treatment of obesity and related metabolic conditions. It targets GLP-1, GIP and glucagon receptors and is being researched for its potential to reduce appetite, promote substantial weight loss and improve blood-sugar and metabolic health. Retatrutide is not currently approved for routine medical use.
Possible Side Effects: In clinical studies, retatrutide has commonly been associated with gastrointestinal effects such as nausea, diarrhoea, vomiting, constipation and decreased appetite. Other potential risks may include changes in heart rate, low blood sugar in certain circumstances, dehydration and gallbladder or pancreatic problems. As retatrutide is still investigational, its full safety profile and long-term side effects have not yet been established.
Reviews
There are no reviews yet.